You're claiming that a cloned kit would not be feasible to be marketed based on regulatory costs and time, if this was the case, why would Avita bother to have patents on ReCell?
Patent extension, page-63
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.53 |
Change
-0.200(7.33%) |
Mkt cap ! $172.2M | |||
| Open | High | Low | Value | Volume |
| $2.59 | $2.61 | $2.53 | $1.062M | 413.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 15328 | $2.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.54 | 812 | 1 |
View Market Depth
| Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
| AVH (ASX) Chart |